Whitehead Institute Members Iain Cheeseman and Siniša Hrvatin have each received a Professor Amar G. Bose Research Grant, which supports ambitious MIT faculty research that may be too early, explorato...

Whitehead Institute researchers reveal how the Toxoplasma parasite reorganizes sugars on the surface of host cells to trigger a critical step in infection.

Malik discusses how external advisors help strengthen Whitehead’s research, why bold science flourishes in a collaborative environment, and what keeps Whitehead Institute at the forefront of discovery...

Whitehead Institute Member Ankur Jain and colleagues have discovered that RNA molecules are naturally prone to sticking together, but cells may have evolved to keep RNA from forming disruptive aggrega...

Alicia Zhou was an undergraduate researcher in Whitehead Institute Founding Member Robert Weinberg’s lab. Here she discusses her career path from academic scientist to CEO, what she learned from Weinb...

The Jane Coffin Childs Memorial Fund for Medical Research (Jane Coffin Childs Fund/JCC Fund) is an unwavering supporter of biomedical research, having funded early-career researchers for nearly ninety...

Fred Hutch names eight recipients of the Dr. Eddie Méndez Award, which celebrates early-career scientists' research in cancer, infectious disease and basic sciences.

Giselle Valdes, a PhD student in the MIT Department of Biology, studies stem cell regeneration and teaches and mentors other MIT biology students, as well as local middle and high school students.

Patrik Ernfors received a PhD in neuroscience from Karolinska Institute and completed postdoctoral training at the Whitehead Institute, MIT, USA. He returned to a faculty position at Karolinska Instit...

From genomics to immunotherapy, the Cancer Research Institute CEO discusses data sharing to accelerate precision cancer care.

Editors’ note: The Ogawa-Yamanaka Stem Cell Prize recognizes groundbreaking work in translational regenerative medicine using reprogrammed cells. The prize is supported by Gladstone Institutes, in par...

Rare disease treatment and care relies on the combined efforts of clinicians, researchers, and families. Yet these people rarely find themselves in the same room. BridgeRD brought together stakeholder...